|
Phenotype Submission - Cystic Fibrosis
|
|
1
|
106
|
September 16, 2023
|
|
Phenotype Submission - CTEPH Procedures
|
|
1
|
69
|
September 16, 2023
|
|
Phenotype Submission - Chronic Thromboembolic Pulmonary Hypertension (WHO Group 4)
|
|
2
|
117
|
September 16, 2023
|
|
Phenotype Submission - Antiphospholipid syndrome
|
|
1
|
61
|
September 16, 2023
|
|
Phenotype Submission - Raynaud’s disease or Raynaud's phenomenon
|
|
1
|
69
|
September 16, 2023
|
|
Phenotype Submission - Overlap syndrome
|
|
1
|
82
|
September 16, 2023
|
|
Phenotype Submission - Undifferentiated connective tissue disease
|
|
1
|
58
|
September 16, 2023
|
|
Phenotype Submission - Mixed connective tissue disease
|
|
1
|
62
|
September 16, 2023
|
|
Phenotype Submission - Antisynthetase syndrome
|
|
1
|
73
|
September 16, 2023
|
|
Phenotype Submission - Inflammatory Bowel Disease
|
|
3
|
83
|
September 16, 2023
|
|
Phenotype Submission - Portal Hypertension
|
|
1
|
76
|
September 16, 2023
|
|
Phenotype Submission - Congenital Heart Disease
|
|
1
|
61
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with lung diseases and/or hypoxia (WHO Group 3)
|
|
2
|
110
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with left heart disease (WHO Group 2)
|
|
2
|
120
|
September 16, 2023
|
|
Phenotype Submission - Scleroderma
|
|
1
|
69
|
September 16, 2023
|
|
Phenotype Submission - Sickle Cell Anemia
|
|
1
|
65
|
September 16, 2023
|
|
Phenotype Submission - Sarcoidosis
|
|
1
|
66
|
September 16, 2023
|
|
Phenotype Submission - Right Heart Failure
|
|
1
|
80
|
September 16, 2023
|
|
Phenotype Submission - PAH Drug Treatment Groups
|
|
1
|
92
|
September 16, 2023
|
|
Phenotype Submission - PAH plus Left Heart Disease
|
|
1
|
65
|
September 16, 2023
|
|
Phenotype Submissions - HowOften - Dual biologic therapy for IBD, PsO, and PsA
|
|
1
|
81
|
September 16, 2023
|
|
Phenotype Submission - Non-infectious uveitis and iridocyclitis
|
|
1
|
108
|
September 15, 2023
|
|
Phenotype Submission - Down Syndrome
|
|
1
|
68
|
September 15, 2023
|
|
Phenotype Submission - Motor Vehicle Accidents (MVA)
|
|
1
|
112
|
September 15, 2023
|
|
Phenotype Submission - Pulmonary Arterial Hypertension (WHO Group 1)
|
|
1
|
105
|
September 14, 2023
|
|
Phenotype Submission - Pulmonary Hypertension
|
|
1
|
101
|
September 14, 2023
|
|
Phenotype submission - Diabetic ketoacidosis
|
|
1
|
105
|
September 8, 2023
|
|
Nested criteria interpretation
|
|
1
|
91
|
September 7, 2023
|
|
Call for collaboration - Myasthenia Gravis PROJECT
|
|
0
|
82
|
September 7, 2023
|
|
Characterization - defining treatment combinations
|
|
0
|
86
|
September 6, 2023
|
